Drug Trial Radar · NCT07087054
Carcinoid Syndrome Efficacy Study Featuring an Oral Daily Paltusotine Regimen
Last checked: Nov 20, 2026Latest source record: Oct 15, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
141
Planned (sponsor's estimate)
Start
Nov 19, 2025
Primary completion
Aug 2027
Study completion Jan 2030
Sponsor
- Lead sponsor
- Crinetics Pharmaceuticals Inc.Industry
- Sponsor type
- Industry
- First posted
- Jul 25, 2025
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
A Phase 3, randomized, double-blinded, placebo-controlled study to evaluate the efficacy and safety of paltusotine treatment vs placebo as well as the long-term safety of paltusotine in adults with carcinoid syndrome due to well-differentiated neuroendocrine tumors. The purpose of this study is to continue the evaluation of the safety, efficacy, and pharmacokinetics (PK) of paltusotine in participants with carcinoid syndrome.
Conditions
- Carcinoid Syndrome
- Carcinoid
- Carcinoid Tumor
- Carcinoid Tumor of Ileum
- Carcinoid Tumor of Cecum
- Carcinoid Tumor of Liver
- Carcinoid Tumor of Pancreas
- Carcinoid Syndrome Diarrhea
- Carcinoid Intestine Tumor
Interventions
PaltusotineDrug
Experimental Drug: Randomized
PlaceboDrug
Matching Placebo Drug: Randomized
Primary outcomes
What the sponsor says the trial is designed to measure.
- Participants will record the number of flushing per day in a daily diary to assess the efficacy of paltusotine vs placebo in reducing flushing episodes.Time frame: Measured at Week 12
Locations
72 sites in 14 countries. Site status is shown where the registry gives one.
Banner MD Anderson Cancer Center
Gilbert, Arizona
Hoag Memorial Hospital Presbyterian
Newport Beach, California
Yale University - New Haven Hospital - Yale Cancer Center
New Haven, Connecticut
University of Miami
Miami, Florida
Moffitt Cancer Center
Tampa, Florida
Winshop Cancer Institute - Emory University
Atlanta, Georgia
University of Iowa Health Care
Iowa City, Iowa
University of Kentucky Medical Center
Lexington, Kentucky
Louisiana State University Health Sciences
Metairie, Louisiana
Henry Ford Cancer - Detroit
Detroit, Michigan
Mayo Clinic
Rochester, Minnesota
Icahn School of Medicine at Mount Sinai
New York, New York
University Hospitals Cleveland Medical Center
Cleveland, Ohio
Hospital of the University of Pennsylvania
Philadelphia, Pennsylvania
Huntsman Cancer Institute, University of Utah
Salt Lake City, Utah
University of Virginia Comprehensive Cancer Center
Charlottesville, Virginia
Medical College of Wisconcin
Milwaukee, Wisconsin
Hospital de Gastroenterologia Dr. Carlos Bonorino Udaondo
Buenos Aires, Argentina
Centro de Endocrinologia y Diabetes Dr. A. Gutman ICM - Investigaciones
Buenos Aires, Argentina
Instituto Médico Especializado Alexander Fleming
Buenos Aires, Argentina
Hospital de Gastroenterologia Dr. Carlos Bonorino Udaondo
CABA, Argentina
Instituto Médico de la Fundación Estudios Clínicos
Santa Fe, Argentina
Universitair Ziekenhuis (UZ) Leuven
Leuven, Belgium
Fundacao PIO XII - Hospital de Amor Barretos
Barretos, Brazil
Sociedade Literaria e Caritativa Santos Agostinho - Hospital Sao José
Criciúma, Brazil
Nucleo de Pesquisa e Desenvolvimento de Medicamentos (MPDM)
Fortaleza, Brazil
Associacao Hospitalar Moinhos de Vento
Porto Alegre, Brazil
Instituto Nacional de Cancer (INCA)
Rio de Janeiro, Brazil
AC Camargo Cancer Center
São Paulo, Brazil, Brazil
CECIM-Centro de Estudios Cliicos e Investigaciones Medicas
Santiago, Chile
Clinical Universidad Catolica del Maule, Ltda
Maule, Chile, Chile
Centro de Oncologia de Precision
Santiago, Chile, Chile
Hospital Universitario San Ignacio
Bogotá, DC, Colombia
Instituto Nacional de Cancerologia
Bogotá, DC, Colombia
CHRU Tours - Hopital Trousseau
Chambray-lès-Tours, France
Hopital Beaujun - APHP
Clichy, France
APHM- Hopital de la Timone
Marseille, France
Centre Hospitalier Universitaire Nantes
Nantes, France
Centre Antoine Lacassagne
Nice, France
Groupe Hospitalier Diaconsses Croix Saint Simon
Paris, France
Showing 40 of 72 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.